RE: rns out cradle arc22 Dec 2017 09:49
From an RNS “On 24 November 2015, Paternoster announced the purchase of US$495,365 (£325,000) of CULS in Alecto in exchange for the issue of 100,000,000 new ordinary shares in Paternoster. Paternoster has now converted all of its holding of CULS into 433,501,250 new ordinary shares in Alecto at a price of 0.08 pence per share. As a result, Paternoster now has a 12.1% shareholding in Alecto which, based on the current Alecto share price of 0.11 pence per share, values Paternoster's shareholding at around £476,900.” And The From today’s Cradle Arc RNS “Anticipated market capitalisation on admission: £20.25 million” looks very profitable